These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23092955)

  • 1. Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome.
    Koutsopoulos OS; Kretz C; Weller CM; Roux A; Mojzisova H; Böhm J; Koch C; Toussaint A; Heckel E; Stemkens D; Ter Horst SA; Thibault C; Koch M; Mehdi SQ; Bijlsma EK; Mandel JL; Vermot J; Laporte J
    Eur J Hum Genet; 2013 Jun; 21(6):637-42. PubMed ID: 23092955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
    Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
    Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
    Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
    Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
    Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
    Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.
    Jungbluth H; Cullup T; Lillis S; Zhou H; Abbs S; Sewry C; Muntoni F
    Neuromuscul Disord; 2010 Jan; 20(1):49-52. PubMed ID: 19932620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice.
    Durieux AC; Vassilopoulos S; Lainé J; Fraysse B; Briñas L; Prudhon B; Castells J; Freyssenet D; Bonne G; Guicheney P; Bitoun M
    Traffic; 2012 Jun; 13(6):869-79. PubMed ID: 22369075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.
    Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P
    Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathy.
    Haberlová J; Mazanec R; Ridzoň P; Baránková L; Nürnberg G; Nürnberg P; Sticht H; Huehne K; Seeman P; Rautenstrauss B
    J Neurogenet; 2011 Dec; 25(4):182-8. PubMed ID: 22091729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in dynamin 2 cause dominant centronuclear myopathy.
    Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
    Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two dynamin-2 genes are required for normal zebrafish development.
    Gibbs EM; Davidson AE; Trickey-Glassman A; Backus C; Hong Y; Sakowski SA; Dowling JJ; Feldman EL
    PLoS One; 2013; 8(2):e55888. PubMed ID: 23418470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common membrane trafficking defects of disease-associated dynamin 2 mutations.
    Liu YW; Lukiyanchuk V; Schmid SL
    Traffic; 2011 Nov; 12(11):1620-33. PubMed ID: 21762456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Dynamin 2 GTPase function results in microcytic anaemia.
    Brown FC; Collett M; Tremblay CS; Rank G; De Camilli P; Booth CJ; Bitoun M; Robinson PJ; Kile BT; Jane SM; Curtis DJ
    Br J Haematol; 2017 Aug; 178(4):616-628. PubMed ID: 28466468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
    Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
    Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.